Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Best Pract Res Clin Gastroenterol. 2013 Jun;27(3):401-14. doi: 10.1016/j.bpg.2013.06.005.
Proton pump inhibitors (PPIs) remove most of the acid from the gastroesophageal refluxate. However, PPIs do not eliminate reflux and the response of specific GERD symptoms to PPI therapy depends on the degree to which acid drives those symptoms. PPIs are progressively less effective for heartburn, regurgitation, chest pain and extra-oesophageal symptoms. Hence, with an incomplete PPI response, obtaining an accurate history, detailing which symptoms are 'refractory' and exactly what evidence exists linking these symptoms to GERD is paramount. Reflux can continue to cause symptoms despite PPI therapy because of persistent acid reflux or weakly acidic reflux. Given these possibilities, diagnostic testing (pH or pH-impedance monitoring) becomes essential. Antireflux surgery is an alternative in patients if a clear relationship is established between persistent symptoms, particularly regurgitation, and reflux. Treating visceral hypersensitivity may also benefit the subset of GERD patients whose symptoms are driven by this mechanism.
质子泵抑制剂(PPIs)可从胃食管反流物中去除大部分酸。然而,PPIs 并不能消除反流,特定 GERD 症状对 PPI 治疗的反应取决于酸驱动这些症状的程度。PPI 对烧心、反流、胸痛和食管外症状的疗效逐渐降低。因此,对于 PPI 反应不完全的患者,获得准确的病史、详细说明哪些症状是“难治性”的以及存在哪些证据将这些症状与 GERD 联系起来至关重要。尽管进行了 PPI 治疗,但由于持续的酸反流或弱酸性反流,反流仍可能继续引起症状。鉴于这些可能性,诊断测试(pH 或 pH 阻抗监测)变得至关重要。如果在持续症状(特别是反流)与反流之间建立了明确的关系,那么对于患者来说,抗反流手术是一种替代方法。治疗内脏高敏性也可能使症状受此机制驱动的 GERD 患者亚组受益。